The company that made humanoid robots affordable
HQ: Hangzhou, China | Founded: 2016 | Employees: ~1,000+ (post-IPO scale; exact figure not disclosed) | Stage: Public (STAR Market, Shanghai) — IPO August 2026; ~$9B pricing valuation, spiked to ~$50B on debut | Website: https://www.unitree.com
Unitree Robotics builds and sells legged and humanoid robots at consumer-electronics prices. It started in 2016 with quadrupeds — first for research labs, then for anyone with a few thousand dollars — and in 2023–2025 extended the same playbook to humanoids: the H1, the G1, and the ultra-cheap R1, alongside the H2 and quadrupeds like the Go2 and industrial B2.
The company's core competence is cost. Wang Xingxing's team designs its own motors, reducers and controllers, and tunes whole-body control software in-house, which is why a Unitree humanoid costs less than some rivals' single actuators. Cheap hardware in developers' hands doubles as R&D: thousands of labs and hobbyists now build on Unitree platforms, an ecosystem effect that compounds.
In August 2026 Unitree became the first humanoid robotics company to go public, listing on Shanghai's STAR Market after the fastest regulatory approval of the year. The prospectus gave the market its first real look at humanoid economics: 2025 revenue near ¥1.7 billion, strong growth in humanoid sales overtaking quadrupeds, and sustained profitability — before shares whipsawed in their first weeks of trading.
Unitree did to robots what Xiaomi did to phones: took a product that cost as much as a car and sold it for the price of a laptop. Founder Wang Xingxing built the company around cheap, capable actuators and control software, starting with quadrupeds (the famous robot-dog videos) and moving to humanoids — the G1 at roughly $13,500 and the R1 from about $4,900, against $100,000+ price tags from Western rivals.
That pricing discipline produced numbers no other humanoid company can show. The IPO prospectus disclosed 2025 revenue of ¥1.7 billion (~$250M), up over 300% year-on-year, gross margins expanding from 44% in 2022 to 60% in 2025, and profitability for several consecutive years. Unitree sold 3,551 humanoid units in January–September 2025 alone, and humanoids have overtaken quadrupeds as the main revenue line.
The August 2026 IPO was a spectacle. Priced at ¥150.8 per share for a ~¥61B (~$9B) valuation — the fastest STAR Market approval of the year — the stock closed up roughly 460% on debut day at about ¥845, briefly valuing the company near $50 billion. By September 2026 shares had fallen some 40–50% from the debut close, erasing roughly $20B of market value, a reminder that the listing priced a dream, not a multiple.
The risks are real: Western governments increasingly treat Chinese robotics as a strategic technology, with US trade and export scrutiny explicitly flagged in the IPO; competition is arriving from better-funded labs (Figure, Tesla's Optimus, UBTech, Fourier, Galbot); and premium-priced humanoids still have to prove durable commercial demand beyond research labs and developers. Unitree's answer has been consistent for a decade — ship the cheapest credible robot first, and let volume teach the machine.
Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki